HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Kölblinger Selected Research

Midkine

12/2020Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Kölblinger Research Topics

Disease

4Melanoma (Melanoma, Malignant)
05/2023 - 12/2020
2Neoplasms (Cancer)
12/2020 - 12/2018
1Skin Neoplasms (Skin Cancer)
05/2023
1Lung Neoplasms (Lung Cancer)
01/2022

Drug/Important Bio-Agent (IBA)

2Immune Checkpoint InhibitorsIBA
01/2022 - 12/2020
1NivolumabIBA
05/2023
1AntibodiesIBA
05/2023
1pembrolizumabIBA
05/2023
1InterferonsIBA
12/2020
1MidkineIBA
12/2020

Therapy/Procedure

2Therapeutics
05/2023 - 01/2022
2Immunotherapy
01/2022 - 01/2022
1Drug Therapy (Chemotherapy)
01/2022
1Chemoprevention
12/2018